Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
Circulation|March 17, 1999
Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine modelA Kumar, M P Villani, U K Patel, et al.Stem Cells (Dayton, Ohio)|January 1, 1994
IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biologyJ C Keith, L Albert, S T Sonis, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1984
Early events in the formation of a venous thrombus following local trauma and stasisR G Schaub, C A Simmons, M H Koets, et al.Molecular Reproduction and Development|January 1, 1997
Immunoreactive macrophage colony-stimulating factor is increased in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits after recombinant human macrophage colony-stimulating factor therapyL H Donnelly, M P Bree, S E Hunter, et al.The American Journal of Pathology|February 1, 1996
Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanismsK E Waldburger, R C Hastings, R G Schaub, et al.Structure (London, England : 1993)|November 17, 2009
A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1Ren-Huai Huang, Daved H Fremont, John L Diener, et al.Journal of Biomedical Materials Research|October 1, 1994
Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in ratsL J Marden, J O Hollinger, A Chaudhari, et al.Journal of Clinical Pharmacology|February 1, 1986
Tolerance and pharmacology of ciprostene, a stable epoprostenol (prostacyclin) analogue in humansO I Linet, E E Nishizawa, R G Schaub, et al.Blood|December 10, 1999
Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunityK Dunussi-Joannopoulos, K Runyon, J Erickson, et al.Circulation|February 27, 2001
Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swineJ G Bienvenu, J F Tanguay, J F Théorêt, et al.Pageof 12